Core Viewpoint - Yuyue Medical is strategically focusing on digitalization and wearable technology, with significant growth in home respiratory devices and overseas sales, indicating a robust market expansion and product innovation strategy. Digitalization and Wearable Technology - The company is integrating digital technology with medical devices, focusing on continuous glucose monitoring (CGM) systems that encompass hardware, software, and algorithms for comprehensive digital application [2] - Yuyue Medical plans to launch AI-powered wearable medical devices aimed at health management, covering various health monitoring scenarios [2][4] - The integration of the Yuyue AIAgent app with the existing health management platform is intended to create a unified health management ecosystem [2] Home Respiratory Devices - Home respiratory device sales grew over 40% year-on-year, driven by the launch of an upgraded sleep apnea machine and enhanced brand strength facilitating import substitution [2][3] - The company is expanding its market presence in Europe and Thailand, with ongoing registration efforts and improved distribution channels [3] Continuous Glucose Monitoring (CGM) - New CGM products, Anytime4 and Anytime5, have received positive user feedback, contributing to the brand's growing market presence [3] - AI technology is being incorporated into CGM product development to enhance service capabilities and user experience [3] Home Health Monitoring Solutions - The home health monitoring segment saw a 15.22% growth, with electronic blood pressure monitors leading the category due to strong user trust and product performance [4] Overseas Business Development - Yuyue Medical achieved 607 million yuan in overseas sales, a 26.63% increase, with respiratory therapy products leading the export growth [5] - The Southeast Asian market, particularly Thailand, has shown rapid growth, with plans to replicate successful strategies in other regions [5][6] Emergency Solutions and Growth Drivers - The "Emergency Solutions and Others" segment reported a 30.54% revenue increase, with emergency product growth outpacing the overall segment [6][7] - Future growth drivers include an expanding product matrix, increasing brand influence, and a significant opportunity for AED penetration in the domestic market [7]

Investment Rating - The investment rating for the company is "Outperform" with a target price of RMB 45.47, down 8% from previous estimates [1][8]. Core Views - The company experienced a revenue decline of 5.09% in 2024, totaling RMB 7.57 billion, and a net profit drop of 24.63% to RMB 1.81 billion. However, Q1 2025 showed a revenue increase of 9.17% to RMB 2.44 billion, indicating a potential recovery [1][8]. - The report highlights the impact of high base effects on revenue, particularly in respiratory solutions, while noting strong growth in glucose management and emergency solutions [9][10]. - Strategic investment in Inogen is expected to enhance overseas expansion and brand strength, with export revenue growing by 30.42% in 2024 [11]. Financial Summary - Revenue for 2024 is projected at RMB 7.57 billion, with a forecasted increase to RMB 8.46 billion in 2025, representing an 11.9% growth [2]. - Net profit attributable to shareholders is expected to recover to RMB 1.98 billion in 2025, up from RMB 1.81 billion in 2024 [2]. - The company’s EPS forecast for 2025 is revised to RMB 1.98, with a new estimate for 2027 at RMB 2.64 [1][2]. Business Segments - Respiratory solutions revenue decreased by 22.42% in 2024 to RMB 2.60 billion, affected by fluctuations in public demand [9]. - Glucose management and POCT solutions saw a significant revenue increase of 40.20% to RMB 1.03 billion, driven by product upgrades and market expansion [10]. - Emergency solutions revenue grew by 34.05% to RMB 239 million, reflecting strong demand for newly certified products [10]. Strategic Initiatives - The strategic investment in Inogen aims to accelerate international market penetration and enhance the company's export capabilities [11]. - The company is focusing on building trust and cooperation with overseas clients, which is expected to yield comprehensive progress in key regions [11].